financetom
Business
financetom
/
Business
/
AptarGroup Nasal Spray to Treat Allergic Reaction Gets FDA Approval
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
AptarGroup Nasal Spray to Treat Allergic Reaction Gets FDA Approval
Aug 15, 2024 3:07 PM

05:54 PM EDT, 08/15/2024 (MT Newswires) -- AptarGroup ( ATR ) said late Thursday that the the US Food and Drug Administration approved Unidose, liquid system, for use with a nasal spray for the emergency treatment of allergic reactions, including anaphylaxis.

Unidose was approved for use with neffy -- epinephrine nasal spray.

Price: 149.49, Change: +2.48, Percent Change: +1.69

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tesla CEO Musk says Austin robotaxi fleet to double next month
Tesla CEO Musk says Austin robotaxi fleet to double next month
Nov 25, 2025
(Reuters) -Tesla Chief Executive Elon Musk said on Tuesday that the number of robotaxis in Austin, Texas, will double in December, following the rollout of its self-driving service in the city in June. The Tesla Robotaxi fleet in Austin should roughly double next month, Musk said in a post on X, which is also owned by him. It is not...
UBS credit funds could face 10% write-down due to First Brands, Handelsblatt reports
UBS credit funds could face 10% write-down due to First Brands, Handelsblatt reports
Nov 25, 2025
ZURICH, Nov 26 (Reuters) - UBS could mark down credit funds managed by its O'Connor hedge fund unit by over 10% following the bankruptcy of U.S. auto parts supplier First Brands, German business paper Handelsblatt reported on Wednesday, citing sources. UBS said earlier this month it was winding down investment funds run by its hedge fund unit O'Connor, with the...
FOCUS-Tesla struggles to course correct from sales skid
FOCUS-Tesla struggles to course correct from sales skid
Nov 25, 2025
* Tesla faces sales pressure in Europe, China and the U.S * European sales fell 48.5% in October, even as industry-wide EV sales rose 26% * Tesla's competition includes Chinese newcomers, improved EVs from legacy players By Nick Carey and Abhirup Roy Nov 26 (Reuters) - Tesla CEO Elon Musk has spent much of this year focused on the carmaker's...
Tesla struggles to course correct from sales skid
Tesla struggles to course correct from sales skid
Nov 25, 2025
(Reuters) -Tesla CEO Elon Musk has spent much of this year focused on the carmaker's robotics pursuits and winning shareholder approval for his freshly minted $1 trillion pay package. In the meantime, the outlook for Tesla's main business - selling cars - is darkening.  Tesla faces sales pressure in the world's three biggest car markets: Europe, China and the United States....
Copyright 2023-2026 - www.financetom.com All Rights Reserved